Fundies.
English

Segment disclosures

Company overview

BIOMERICA, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

12 dimension combinations 126 retained observations 19 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Asia

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:AsiaMember
PeriodValueUnitFiledEvidence
2011-06-01 – 2012-05-312420000 USD20120829Open filing evidence
2010-06-01 – 2011-05-311153000 USD20120829Open filing evidence

Clinical Lab

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:ClinicalLabMember
PeriodValueUnitFiledEvidence
2022-12-01 – 2023-02-28532000 USD20230414Open filing evidence
2022-06-01 – 2023-02-282580000 USD20230414Open filing evidence
2022-09-01 – 2022-11-30902000 USD20230113Open filing evidence
2022-06-01 – 2022-11-302048000 USD20230113Open filing evidence
2022-06-01 – 2022-08-311146000 USD20221013Open filing evidence
2021-06-01 – 2022-05-313064000 USD20220829Open filing evidence
2021-12-01 – 2022-02-28731000 USD20230414Open filing evidence
2021-06-01 – 2022-02-282259000 USD20230414Open filing evidence
2021-09-01 – 2021-11-30642000 USD20230113Open filing evidence
2021-06-01 – 2021-11-301528000 USD20230113Open filing evidence
2021-06-01 – 2021-08-31886000 USD20221013Open filing evidence
2020-06-01 – 2021-05-313077000 USD20220829Open filing evidence
2020-12-01 – 2021-02-28967000 USD20220414Open filing evidence
2020-06-01 – 2021-02-282441000 USD20220414Open filing evidence
2020-09-01 – 2020-11-30893000 RestatedUSD20220112Open filing evidence
2020-06-01 – 2020-11-301475000 RestatedUSD20220112Open filing evidence
2020-06-01 – 2020-08-31582000 RestatedUSD20211014Open filing evidence
2019-06-01 – 2020-05-312922000 RestatedUSD20211014Open filing evidence
2019-12-01 – 2020-02-29723000 USD20210414Open filing evidence
2019-06-01 – 2020-02-292769000 USD20210414Open filing evidence
2019-09-01 – 2019-11-301144172 USD20210114Open filing evidence
2019-06-01 – 2019-11-302034228 USD20210114Open filing evidence
2019-06-01 – 2019-08-31890152 USD20201015Open filing evidence
2018-06-01 – 2019-05-314043993 USD20200831Open filing evidence
2018-12-01 – 2019-02-281043000 USD20200414Open filing evidence
2018-06-01 – 2019-02-283150000 USD20200414Open filing evidence

Contract Manufacturing

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:ContractManufacturingMember
PeriodValueUnitFiledEvidence
2022-12-01 – 2023-02-28284000 USD20230414Open filing evidence
2022-06-01 – 2023-02-28431000 USD20230414Open filing evidence
2022-09-01 – 2022-11-3052000 USD20230113Open filing evidence
2022-06-01 – 2022-11-30147000 USD20230113Open filing evidence
2022-06-01 – 2022-08-3195000 USD20221013Open filing evidence
2021-06-01 – 2022-05-31459000 USD20220829Open filing evidence
2021-12-01 – 2022-02-28167000 USD20230414Open filing evidence
2021-06-01 – 2022-02-28319000 USD20230414Open filing evidence
2021-09-01 – 2021-11-30112000 USD20230113Open filing evidence
2021-06-01 – 2021-11-30152000 USD20230113Open filing evidence
2021-06-01 – 2021-08-3140000 USD20221013Open filing evidence
2020-06-01 – 2021-05-31555000 RestatedUSD20220829Open filing evidence
2020-12-01 – 2021-02-28130000 USD20220414Open filing evidence
2020-06-01 – 2021-02-28364000 RestatedUSD20220414Open filing evidence
2020-09-01 – 2020-11-3055000 RestatedUSD20220112Open filing evidence
2020-06-01 – 2020-11-30233000 RestatedUSD20220112Open filing evidence
2020-06-01 – 2020-08-31180000 RestatedUSD20211014Open filing evidence
2019-06-01 – 2020-05-31306000 RestatedUSD20211014Open filing evidence
2019-12-01 – 2020-02-29151000 USD20210414Open filing evidence
2019-06-01 – 2020-02-29264000 USD20210414Open filing evidence
2019-09-01 – 2019-11-3052225 USD20210114Open filing evidence
2019-06-01 – 2019-11-30111993 USD20210114Open filing evidence
2019-06-01 – 2019-08-3159832 USD20201015Open filing evidence
2018-06-01 – 2019-05-31117213 USD20200831Open filing evidence
2018-12-01 – 2019-02-2839000 USD20200414Open filing evidence
2018-06-01 – 2019-02-2890000 USD20200414Open filing evidence

Europe

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:EuropeMember
PeriodValueUnitFiledEvidence
2011-06-01 – 2012-05-312533000 USD20120829Open filing evidence
2010-06-01 – 2011-05-312483000 USD20120829Open filing evidence

Lab Supplies

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:LabSuppliesMember
PeriodValueUnitFiledEvidence
2020-06-01 – 2021-05-313000 USD20211014Open filing evidence
2020-06-01 – 2021-02-283000 USD20210414Open filing evidence
2020-09-01 – 2020-11-302884 USD20210114Open filing evidence
2020-06-01 – 2020-11-302884 USD20210114Open filing evidence

Middle East

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:MiddleEastMember
PeriodValueUnitFiledEvidence
2011-06-01 – 2012-05-3122000 USD20120829Open filing evidence
2010-06-01 – 2011-05-3145000 USD20120829Open filing evidence

OTC

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:OTCMember
PeriodValueUnitFiledEvidence
2020-12-01 – 2021-02-28148000 USD20210414Open filing evidence
2020-06-01 – 2021-02-28605000 USD20210414Open filing evidence
2020-09-01 – 2020-11-30272223 USD20210114Open filing evidence
2020-06-01 – 2020-11-30457131 USD20210114Open filing evidence
2020-06-01 – 2020-08-31184908 USD20201015Open filing evidence
2019-06-01 – 2020-05-311269535 USD20200831Open filing evidence
2019-12-01 – 2020-02-29271000 USD20210414Open filing evidence
2019-06-01 – 2020-02-29778000 USD20210414Open filing evidence
2019-09-01 – 2019-11-30320785 USD20210114Open filing evidence
2019-06-01 – 2019-11-30520109 USD20210114Open filing evidence
2019-06-01 – 2019-08-31199209 USD20201015Open filing evidence
2018-06-01 – 2019-05-31868605 USD20200831Open filing evidence
2018-12-01 – 2019-02-28131000 USD20200414Open filing evidence
2018-06-01 – 2019-02-28653000 USD20200414Open filing evidence

Other Foreign

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:OtherForeignMember
PeriodValueUnitFiledEvidence
2011-06-01 – 2012-05-3130000 USD20120829Open filing evidence
2010-06-01 – 2011-05-3130000 USD20120829Open filing evidence

Overthecounter

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:OverthecounterMember
PeriodValueUnitFiledEvidence
2022-12-01 – 2023-02-28292000 USD20230414Open filing evidence
2022-06-01 – 2023-02-28971000 USD20230414Open filing evidence
2022-09-01 – 2022-11-30466000 USD20230113Open filing evidence
2022-06-01 – 2022-11-30679000 USD20230113Open filing evidence
2022-06-01 – 2022-08-31213000 USD20221013Open filing evidence
2021-06-01 – 2022-05-311089000 USD20220829Open filing evidence
2021-12-01 – 2022-02-28244000 USD20230414Open filing evidence
2021-06-01 – 2022-02-28857000 USD20230414Open filing evidence
2021-09-01 – 2021-11-30534000 USD20230113Open filing evidence
2021-06-01 – 2021-11-30613000 USD20230113Open filing evidence
2021-06-01 – 2021-08-3179000 USD20221013Open filing evidence
2020-06-01 – 2021-05-31766000 USD20220829Open filing evidence
2020-12-01 – 2021-02-28148000 USD20220414Open filing evidence
2020-06-01 – 2021-02-28605000 USD20220414Open filing evidence
2020-09-01 – 2020-11-30272000 USD20220112Open filing evidence
2020-06-01 – 2020-11-30457000 USD20220112Open filing evidence
2020-06-01 – 2020-08-31185000 USD20211014Open filing evidence
2019-06-01 – 2020-05-311270000 USD20211014Open filing evidence

Physicians Office

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:PhysiciansOfficeMember
PeriodValueUnitFiledEvidence
2022-12-01 – 2023-02-284000 USD20230414Open filing evidence
2022-06-01 – 2023-02-28249000 USD20230414Open filing evidence
2022-09-01 – 2022-11-3062000 USD20230113Open filing evidence
2022-06-01 – 2022-11-30245000 USD20230113Open filing evidence
2022-06-01 – 2022-08-31183000 USD20221013Open filing evidence
2021-06-01 – 2022-05-3114259000 USD20220829Open filing evidence
2021-12-01 – 2022-02-286518000 USD20230414Open filing evidence
2021-06-01 – 2022-02-2810134000 USD20230414Open filing evidence
2021-09-01 – 2021-11-303359000 USD20230113Open filing evidence
2021-06-01 – 2021-11-303616000 USD20230113Open filing evidence
2021-06-01 – 2021-08-31257000 USD20221013Open filing evidence
2020-06-01 – 2021-05-312801000 USD20220829Open filing evidence
2020-12-01 – 2021-02-282384000 USD20220414Open filing evidence
2020-06-01 – 2021-02-282735000 USD20220414Open filing evidence
2020-09-01 – 2020-11-30153000 RestatedUSD20220112Open filing evidence
2020-06-01 – 2020-11-30351000 RestatedUSD20220112Open filing evidence
2020-06-01 – 2020-08-31197000 RestatedUSD20211014Open filing evidence
2019-06-01 – 2020-05-312195000 RestatedUSD20211014Open filing evidence
2019-12-01 – 2020-02-2932000 USD20210414Open filing evidence
2019-06-01 – 2020-02-29157000 USD20210414Open filing evidence
2019-09-01 – 2019-11-3079226 USD20210114Open filing evidence
2019-06-01 – 2019-11-30124493 USD20210114Open filing evidence
2019-06-01 – 2019-08-3145222 USD20201015Open filing evidence
2018-06-01 – 2019-05-31170871 USD20200831Open filing evidence
2018-12-01 – 2019-02-2848000 USD20200414Open filing evidence
2018-06-01 – 2019-02-28142000 USD20200414Open filing evidence

South America

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:SouthAmericaMember
PeriodValueUnitFiledEvidence
2011-06-01 – 2012-05-312000 USD20120829Open filing evidence
2010-06-01 – 2011-05-3128000 USD20120829Open filing evidence

United States

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bmra:UnitedStatesMember
PeriodValueUnitFiledEvidence
2011-06-01 – 2012-05-311074000 USD20120829Open filing evidence
2010-06-01 – 2011-05-311160000 USD20120829Open filing evidence